Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America

Author:

Soneji SamirORCID,Beltrán-Sánchez Hiram,Yang Jae Won,Mann Caroline

Abstract

AbstractAs of 31 January 2021, 63.9 million cases and 1.4 million deaths had been reported in Europe and North America, which accounted for 62.5% and 62.4% of the global total, respectively. Comparing the level of mortality across countries has proven difficult because of inherent limitations in the most commonly cited measures (e.g., case-fatality rates). We collected the cumulative number of confirmed deaths from COVID-19 by age in 2020 from the L’Institut National d’études Démographiques (INED) database and Statistics Canada for 15 European and North American countries. We calculated age-specific death rates and age-standardized death rates (ASDR) for each country over a 1-year period from 6 February 2020 (date of first COVID-19 death in Europe and North America) to 5 February 2021 using established demographic methods. We estimated that COVID-19 was the second leading cause of death behind cancer in England and Wales and France and the third leading cause of death behind cancer and heart disease in nine countries including the US. Countries with higher all-cause mortality prior to the COVID-19 experienced higher COVID-19 mortality than countries with lower all-cause mortality prior to the pandemic. The COVID-19 ASDR varied substantially within country (e.g., a 5-fold difference among the highest and lowest mortality states in Germany). Consistently strong public health measures may have lessened the level of mortality for some European and North American countries. In contrast, many of the largest countries and economies in these regions may continue to experience a high mortality level because of poor implementation and adherence to such measures.

Funder

National Institute of Child Health and Human Development

Publisher

Springer Science and Business Media LLC

Subject

Demography

Reference59 articles.

1. 25 Swedish doctors and scientists. Sweden hoped herd immunity would curb COVID-19. Don’t do what we did. It’s not working. USA TODAY. Published July 21, 2020. https://www.usatoday.com/story/opinion/2020/07/21/coronavirus-swedish-herd-immunity-drove-up-death-toll-column/5472100002/. Accessed 27 Oct 2020.

2. Adam K. Second wave of Covid-19 in Europe leads to new restrictions but no national lockdowns. Washington Post. https://www.washingtonpost.com/world/europe/covid-europe-second-wave/2020/10/12/8aacfadc-0c66-11eb-b404-8d1e675ec701_story.html. Published October 12, 2020. Accessed 27 Oct 2020.

3. Age and Sex. United States Census Bureau. Published 2018. https://data.census.gov/cedsci/table?g=0100000US_0400000US09,10,11,24,25,34,36,42&y=2018&tid=ACSST1Y2018.S0101&tp=false&hidePreview=true. Accessed 14 Oct 2020.

4. All state comparison of testing efforts. (n.d.) Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/testing/states-comparison. Accessed 14 Oct 2020

5. Barone E. Why some people are waiting weeks for their COVID-19 test results. Time. Published October 12, 2020. https://time.com/5878732/covid-19-testing-delays/. Accessed 15 Oct 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3